Briggs Morrison

AstraZeneca to present new data from its growing inflammation and autoimmunity portfolio at the American College of Rheumatology (ACR) 2014 Annual Meeting in Boston, 14-19 November 2014

LONDON, 11-11-2014 — /EuropaWire/ — AstraZeneca, with its global biologics research and development arm, MedImmune, will present new data from…

9 years ago

AstraZeneca and Bristol-Myers Squibb Company announce US FDA approved FARXIGA™ (dapagliflozin) for type 2 diabetes adult patients treatment

London, UK, 15-1-2014 — /EuropaWire/ — AstraZeneca and Bristol-Myers Squibb Company announced the US Food and Drug Administration (FDA) approved FARXIGA™ [far-SEE-ga]…

10 years ago